Table 3 Viral suppression using different thresholds disaggregated by regimen for patients taking ART for > 6 months
Viral load (copies/mL) | Overall | Dolutegravir-based regimen | Efavirenz-based regimen | Others | p-value | |||
|---|---|---|---|---|---|---|---|---|
N = 1,941 | N = 1,427 | 95% CI | N = 485 | 95% CI | N = 29 | 95% CI | ||
< 1000 | 1,715 (88.4) | 1,277 (89.5) | 87.8, 91.0 | 418 (86.2) | 82.7, 89.1 | 20 (69.0) | 49.0, 84.0 | 0.002 |
< 400 | 1,680 (86.6) | 1,256 (88.0) | 86.2, 89.6 | 405 (83.5) | 79.8, 86.6 | 19 (65.5) | 45.7, 81.4 | < 0.001 |
< 200 | 1,643 (84.6) | 1,223 (85.7) | 83.8, 87.5 | 402 (82.9) | 79.2, 86.1 | 18 (62.1) | 42.4, 78.7 | 0.002 |
< 50 | 1,487 (76.6) | 1,098 (76.9) | 74.7, 79.1 | 375 (77.3) | 73.3, 80.9 | 14 (48.3) | 29.9, 67.1 | 0.001 |
< 20 | 1,359 (70.0) | 995 (69.7) | 67.3, 72.1 | 350 (72.2) | 67.9, 76.1 | 14 (48.3) | 29.9, 67.1 | 0.022 |
≥ 50, < 1000 | 228 (11.7) | 179 (12.5) | 10.9, 14.4 | 43 (8.9) | 6.6, 11.8 | 6 (20.7) | 8.71, 40.3 | 0.023 |